Catalog No.
YHC24201
Expression system
E. coli
Species
Homo sapiens (Human)
Protein length
Ile25-Pro261
Predicted molecular weight
28 kDa
Nature
Recombinant
Endotoxin level
Please contact with the lab for this information.
Purity
>90% as determined by SDS-PAGE.
Accession
P07288
Applications
ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Form
Lyophilized
Storage buffer
Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.
Reconstitution
Reconstitute in sterile water for a stock solution.
Shipping
In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Alternative Names
Prostate-specific antigen, PSA, 3.4.21.77, Gamma-seminoprotein, Seminin, Kallikrein-3, P-30 antigen, Semenogelase, KLK3, APS
Photoelectrochemical Biosensor Based on 1D In2O3 Tube Decorated with 2D ZnIn2S4 Nanosheets for Sensitive PSA Detection., PMID:40497902
A temperature-responsive regulator that enhances virulence in the kiwifruit canker pathogen Pseudomonas syringae pv. actinidiae., PMID:40487197
Drug survival, long-term safety and efficacy of anti-TNF-alpha biosimilars: a monocentric retrospective study., PMID:40485573
Drug treatment options of high-risk biochemically recurrent prostate cancer based on efficacy and safety: a systematic review and Bayesian network analysis., PMID:40481546
A CRISPR/Cas12a-powered liquid crystal aptasensor for point-of-care detection of prostate-specific antigen for early-stage cancer diagnosis., PMID:40480143
PSA inhibitors for contraception: insights from prostate cancer., PMID:40473484
FAPI Uptake in Malignant Ascites: A Case Report., PMID:40472273
Combined treatment with anti-PSMA antibody and human peripheral blood-derived NK cells for castration-resistant prostate cancer., PMID:40469300
Nanomaterial-based biosensors for cancer diagnosis: trends and innovations (2022-2025)., PMID:40465004
Risk factors and risk-stratification model of biochemical failure in patients with positive surgical margin after robot-assisted radical prostatectomy., PMID:40464999
Identification of distinct disease activity trajectories in patients with psoriatic arthritis receiving tofacitinib: a post hoc analysis of two phase 3 studies., PMID:40461265
CpG dinucleotide methylation of the SPDEF gene as a blood-based epigenetic biomarker for prostate cancer diagnosis., PMID:40457266
Evaluating PSA dynamics for predicting androgen deprivation failure with a patient specific prostate cancer model., PMID:40456781
Efficacy and safety of izokibep in patients with active psoriatic arthritis: a randomised, double-blind, placebo-controlled, phase 2 study., PMID:40455082
Practical Recommendations on Cardiovascular Risk Evaluation in Patients With Psoriasis and Psoriatic Arthritis for Dermatologists, Rheumatologists, and Primary Care Physicians by the Psoriasis and Psoriatic Arthritis Clinics Multicenter Advancement Network., PMID:40454109
Serum immunoreactivity to neurofilament-medium shows high sensitivity and specificity in patients with Behçet disease., PMID:40447321
Identification of therapeutic targets for psoriatic arthritis through proteomics., PMID:40439986
Integrating Magnetic Resonance Chemical Shift Imaging for Localized Prostate Cancer Risk Stratification on the Basis of the Impact of Periprostatic Brown Adipocytes Within Tumor Microenvironment., PMID:40437336
Xanthogranulomatous prostatitis: benign prostate infection masquerading as invasive prostate cancer on MRI and PET-PSMA., PMID:40436425
Predicting prostate cancer metastasis in Ghana: Comparison of multiparametric and PSA models., PMID:40435335
Trace Element Deficiency in Axial Spondyloarthritis and Psoriatic Arthritis in Relation to Markers of Inflammation and Remission., PMID:40430066
Pilot Investigation on Markers of Bone Metabolism, Angiogenesis, and Neuroendocrine Activity as Potential Predictors of Survival of Metastatic Prostate Cancer Patients with Bone Metastases., PMID:40429810
Can Circulating MicroRNAs, Cytokines, and Adipokines Help to Differentiate Psoriatic Arthritis from Erosive Osteoarthritis of the Hand? A Case-Control Study., PMID:40429765
Biochemical Recurrence in High-Risk Localized Prostate Cancer: A Comparison of Laparoscopic Prostatectomy and External Radiotherapy., PMID:40428886
Multitracer comparison of gold standard PSMA-PET/CT with 68Ga-FAPI and 18F-FDG in high-risk prostate cancer: a proof-of-concept study., PMID:40423777
CD4+ tissue-resident memory Th17 cells are a major source of IL-17A in Spondyloarthritis synovial tissue., PMID:40413112
A Supramolecular Material for Controlling Kiwifruit Bacterial Canker., PMID:40411415
A six-month weight loss intervention is associated with significant changes in serum biomarkers related to inflammation, bone and cartilage metabolism in obese patients with psoriatic arthritis and matched controls., PMID:40410839
Correlation analysis of circulating PCDH17 DNA methylation changes with rheumatoid arthritis patients., PMID:40410297
Real-world safety assessment of Ixekizumab based on the FDA Adverse Event Reporting System (FAERS)., PMID:40408459
Estimating the Optimal Time to Perform a Positron Emission Tomography With Prostate-Specific Membrane Antigen in Prostatectomized Patients, Based on Data From Clinical Practice., PMID:40401727
RB1 and p53 are diagnostic markers for treatment-related neuroendocrine prostate cancer: a clinical and pathological analysis of 23 cases., PMID:40401001
Combining Clinical, Genetic and Protein Markers Using Machine Learning Models Discriminates Psoriatic Arthritis Patients From Those With Psoriasis., PMID:40400532
Reevaluating the therapeutic role of extended lymph node dissection in the era of robot-assisted radical prostatectomy., PMID:40399311
Characterization of RNA editing gene APOBEC3C as a candidate tumor suppressor in prostate cancer., PMID:40399289
Real-World Experience with Triplet Therapy for High-Volume Metastatic Castration-Sensitive Prostate Cancer: A Retrospective Cohort Study from a Japanese Academic Hospital., PMID:40399117
Incidental bulbar urethral glomus tumour of uncertain malignant potential with concurrent prostate cancer., PMID:40398908
Exploring Monomer-Amino Acid Interactions in Mimicking Mips for PSA Detection-Using the Novel MBASM Approach., PMID:40396479
Saw Palmetto Extract Ameliorates Benign Prostatic Hyperplasia by Regulating 5α-Reductase and Apoptosis In Vitro and In Vivo., PMID:40395126
Targeting PCNA/AR interaction inhibits AR-mediated signaling in castration resistant prostate cancer cells., PMID:40391771
Association of clinical and sonographic factors with discrepancy between patients' and evaluators' global assessments in psoriatic arthritis., PMID:40388186
Plasmonic coffee-ring biosensing for AI-assisted point-of-care diagnostics., PMID:40382337
Trastuzumab deruxtecan versus trastuzumab emtansine for human epidermal growth factor receptor 2 positive metastatic breast cancer: cost-effectiveness analysis from Iranian experience., PMID:40380283
Intracerebral hemorrhage (hemorrhagic stroke) secondary to Bothrops spp. snakebite envenomation in a horse., PMID:40379034
Optimal adaptive therapeutic schedules for metastatic castrate-resistant prostate cancer based on bilevel optimization problem., PMID:40377664
[Efficacy and Side Effects of Lutetium-177 PSMA-617 in Patients with Castration Resistant Metastatic Prostate Cancer: A Systematic Review and Meta- analysis]., PMID:40377590
Molecular imaging of psoriatic arthritis., PMID:40377474
Prostate-specific antigen doubling time in prostate cancer: a review of calculation methods and clinical implications., PMID:40371530
Modeling protective meningococcal antibody responses and factors influencing antibody persistence following vaccination with MenAfriVac using machine learning., PMID:40367245
For research use only. Not for human or drug use.
